Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 May;149(5):2484-93.
doi: 10.1210/en.2007-1697. Epub 2008 Jan 24.

Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone

Affiliations
Comparative Study

Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone

Edith Sánchez et al. Endocrinology. 2008 May.

Abstract

To determine whether endotoxin-induced activation of type 2 iodothyronine deiodinase (D2) in the mediobasal hypothalamus is dependent on circulating levels of corticosterone, the effect of bacterial lipopolysaccharide (LPS) on D2 gene expression was studied in adrenalectomized, corticosterone-clamped adult, male, Sprague Dawley rats. In sham-adrenalectomized animals, LPS (250 microg/100 g body weight) increased circulating levels of corticosterone and IL-6, as well as tanycyte D2 mRNA in the mediobasal hypothalamus. Adrenalectomized, corticosterone-clamped animals showed no significant rise in corticosterone after LPS, compared with saline-treated controls but increased IL-6 levels and tanycyte D2 mRNA similar to LPS-treated sham controls. To further clarify the potential role of corticosterone in the regulation of D2 gene expression by LPS, animals were administered high doses of corticosterone to attain levels similar to that observed in the LPS-treated group. No significant increase in D2 mRNA was observed in the mediobasal hypothalamus with the exception of a small subpopulation of cells in the lateral walls of the third ventricle. These data indicate that the LPS-induced increase in D2 mRNA in the mediobasal hypothalamus is largely independent of circulating corticosterone and indicate that mechanisms other than adrenal activation are involved in the regulation of most tanycyte D2-expressing cells by endotoxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dark-field photomicrographs showing D2 mRNA in the mediobasal hypothalamus (MBH) after a single dose of LPS (250 μg/100 g BW). A, D2 mRNA (arrows) is present in tanycytes lining the floor and infralateral walls of the third ventricle and increases 3 (B), 6 (C), and 9 h (D) after LPS administration, with the maximal response reached between 6 and 9 h. E, Twelve hours after LPS, the D2 response is beginning to decline. F, Computerized image analysis of D2 mRNA in the MBH after saline and LPS administration. Data represent mean ± sem of three animals per group. **, P < 0.01; ***, P < 0.001. III, Third ventricle; ME, median eminence. Scale bar, 200 μm.
Figure 2
Figure 2
Effect of corticosterone replacement on IL-6 levels in LPS-treated animals. A, IL-6 levels rise approximately 7-fold after administration of LPS in both sham and adrenalectomized animals treated with a 30% corticosterone pellet. SH, Sham; CHOL, cholesterol; SAL, saline; ADX, adrenalectomized; CORT, corticosterone. B, In contrast, significant diminution of the response is observed in adrenalectomized animals replaced with a 45% corticosterone pellet. Data represent the mean ± sem of four to eight animals (sham groups) or five to 10 animals (adrenalectomized groups). **, P < 0.01; ***, P < 0.001.
Figure 3
Figure 3
Effect of LPS on circulating corticosterone levels in sham-adrenalectomized controls and adrenalectomized animals treated with a 30% corticosterone pellet. Data represent mean ± sem of animals described in Fig 2. ***, P < 0.001. CHOL, Cholesterol; SAL, saline; ADX, adrenalectomized; CORT, corticosterone.
Figure 4
Figure 4
Dark-field photomicrographs showing D2 mRNA in the mediobasal hypothalamus (MBH) of sham-adrenalectomized controls implanted sc with a cholesterol pellet and treated with either saline (A) or LPS (B), compared with adrenalectomized rats replaced with a 30% corticosterone pellet and similarly treated with saline (C) or LPS (D). D2 mRNA is significantly increased after LPS in the walls of the third ventricle (III) and median eminence (ME) in both sham and adrenalectomized animals. E, Computerized image analysis of D2 mRNA in the MBH after saline and LPS administration. SH, Sham; CHOL, cholesterol; SAL, saline; ADX, adrenalectomized; CORT, corticosterone. Data represent mean ± sem of animals described in Fig 2. **, P < 0.01. Scale bar, 200 μm.
Figure 5
Figure 5
Circulating corticosterone levels after ip administration of LPS or sc administration of high-dose corticosterone (Cort). Data represent the mean ± sem of four to eight animals (saline control and LPS treated) or six animals [vehicle (50% ethanol in saline) and high dose corticosterone]. **, P < 0.01.
Figure 6
Figure 6
Dark-field photomicrographs of D2 mRNA expression in the mediobasal hypothalamus (MBH) 9 h after animals received either ip injections of saline (A) and 250 μg/100 g BW LPS (B) or sc injections of vehicle (50% ethanol in saline) (C) and high-dose corticosterone (D). Note that D2 mRNA expression is significantly increased only in the MBH of the LPS-treated animals, whereas high-dose corticosterone has no significant effect. E, Computerized image analysis of D2 mRNA in the MBH of saline, LPS, vehicle, and high-dose corticosterone (Cort)-treated animals. Data represent mean ± sem of six to eight animals in each group. ***, P < 0.001. III, Third ventricle. Scale bar, 120 μm.
Figure 7
Figure 7
A, D2 mRNA expression in the lateral walls of the third ventricle. Groups are as shown in Fig. 6. Cort, Corticosterone. B, In situ hybridization autoradiogram of D2 mRNA showing the region (bracketed) analyzed in A. Data represent mean ± sem. *, P < 0.05; ***, P < 0.001.

Similar articles

Cited by

References

    1. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38–89 - PubMed
    1. Kohrle J 2000 The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev Endocr Metab Disord 1:49–58 - PubMed
    1. Lechan RM, Fekete C 2005 Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15:883–897 - PubMed
    1. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR, Lechan RM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138:3359–3368 - PubMed
    1. Guadano-Ferraz A, Obregon MJ, St. Germain DL, Bernal J 1997 The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci USA 94:10391–10396 - PMC - PubMed

Publication types

MeSH terms